Search Results - "Cucevic, Branka"

Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 study by Ciuleanu, Tudor, MD, Brodowicz, Thomas, MD, Zielinski, Christoph, Prof, Kim, Joo Hang, MD, Krzakowski, Maciej, Prof, Laack, Eckart, MD, Wu, Yi-Long, Prof, Bover, Isabel, MD, Begbie, Stephen, MD, Tzekova, Valentina, MD, Cucevic, Branka, MD, Pereira, Jose Rodrigues, MD, Yang, Sung Hyun, MD, Madhavan, Jayaprakash, MD, Sugarman, Katherine P, MD, Peterson, Patrick, PhD, John, William J, MD, Krejcy, Kurt, MD, Belani, Chandra P, Dr

“…Summary Background Several studies have shown the efficacy, tolerability, and ease of administration of pemetrexed—an antifolate antineoplastic agent—in…”
Get full text

Quality of life in patients with advanced non-small-cell lung cancer given maintenance treatment with pemetrexed versus placebo (H3E-MC-JMEN): results from a randomised, double-blind, phase 3 study by Belani, Chandra P, Prof, Brodowicz, Thomas, MD, Ciuleanu, Tudor E, MD, Krzakowski, Maciej, Prof, Yang, Sung Hyun, MD, Franke, Fábio, MD, Cucevic, Branka, MD, Madhavan, Jayaprakash, MD, Santoro, Armando, MD, Ramlau, Rodryg, MD, Liepa, Astra M, PharmD, Visseren-Grul, Carla, MD, Peterson, Patrick, PhD, John, William J, MD, Zielinski, Christoph C, Prof

“…Summary Background Pemetrexed maintenance therapy significantly improved overall survival and progression-free survival compared with placebo, and had a good…”
Get full text

Stress cardiomyopathy following acute ischemic stroke during flexible bronchoscopy: a rare sequence of complications by Badovinac, Sonja, Korsic, Marta, Cucevic, Branka, Slivnjak, Valentina, Dugac, Andrea Vukic, Jakopovic, Marko

Get full text

Erlotinib-related rhabdomyolysis: the role of pharmacogenetics and drug–drug interaction by Koršić, Marta, Muršić, Davorka, Badovinac, Sonja, Božina, Nada, Roglić, Mihovil, Jakopović, Marko, Čučević, Branka

Get full text

Talc pleurodesis improves survival of patients with malignant pleural effusions: case-control study by Korsic, Marta, Badovinac, Sonja, Cucevic, Branka, Janevski, Zoran

“…Summary Aim The aim of this study is to investigate whether there was a considerable difference in the survival of patients with malignant pleural effusion…”
Get full text

Waist circumference does not correlate with functional lung capacity in moderate and severe chronic obstructive pulmonary disease by Popović-Grle, Sanja, Ladić, Agata, Butorac-Petanjek, Bojana, Spicek-Macan, Jasna, Cucević, Branka

“…Waist circumference is a good predictor of the risk of heart diseases, but data on the relationship between waist circumference and pulmonary diseases are…”
Get full text

Cisplatin and gemcitabine first-line chemotherapy followed by maintenance gemcitabine or best supportive care in advanced non-small cell lung cancer: A phase III trial by Brodowicz, Thomas, Krzakowski, Maciej, Zwitter, Matjaz, Tzekova, Valentina, Ramlau, Rodryg, Ghilezan, Nicolae, Ciuleanu, Tudor, Cucevic, Branka, Gyurkovits, Kalman, Ulsperger, Ernst, Jassem, Jacek, Grgic, Mislav, Saip, Pinar, Szilasi, Maria, Wiltschke, Christoph, Wagnerova, Maria, Oskina, Natalya, Soldatenkova, Victoria, Zielinski, Christoph, Wenczl, Miklos

“…The primary objective of this randomized phase III study was to show significant difference in median time to progression (TTP) in patients with advanced NSCLC…”
Get full text

First experience with osimertinib in patients with T790M mutation previously treated with EGFR – TKIs in Croatia by Jakopovic, Marko, Bitar, Lela, Cucevic, Branka, Plestina, Sanja, Mazuranic, Ivica, Seiwerth, Sven, Hecimovic, Ana, Vukic Dugac, Andrea, Jankovic, Mateja, Redzepi, Gzim, Samarzija, Miroslav

“…Abstract only e20518 Background: EGFR T790M mutation is responsible for around 60% cases of resistance to epidermal growth factor receptor (EGFR) tyrosine…”
Get full text

Rates of EGFR, KRAS and ALK gene changes in lung cancer patients in Croatia by Jakopovic, Marko, Brcic, Luka, Misic, Marija, Seiwerth, Fran, Drpa, Gordana, Cucevic, Branka, Plestina, Sanja, Roglic, Mihovil, Kukulj, Suzana, Smojver-Jezek, Silvana, Seiwerth, Sven, Samarzija, Miroslav

“…Abstract only…”
Get full text

The effect of emergency presentation on survival of lung cancer patients by Jakopovic, Marko, Bitar, Lela, Markelic, Ivona, Seiwerth, Fran, Dzubur, Fedza, Hecimovic, Ana, Cucevic, Branka, Mazuranic, Ivica, Redzepi, Gzim, Vukic Dugac, Andrea, Jankovic Makek, Mateja, Samarzija, Miroslav

“…Abstract only…”
Get full text

Effects of Inbreeding, Endogamy, Genetic Admixture, and Outbreeding on Human Health: A “1001 Dalmatians” Study by Rudan, Igor, Biloglav, Zrinka, Vorko-Jović, Ariana, Kujundžić-Tiljak, Mirjana, Stevanović, Ranko, Ropac, Darko, Puntarić, Dinko, Čučević, Branka, Salzer, Branka, Campbell, Harry

Get full text

Cancer-related inflammation as predicting tool for treatment outcome in locally advanced and metastatic non-small cell lung cancer by Badovinac, Sonja, Korsic, Marta, Mursic, Davorka, Samarzija, Miroslav, Cucevic, Branka, Roglic, Mihovil, Jakopovic, Marko

“…Lung cancer is the leading cause of cancer deaths and the non-small cell lung cancer (NSCLC) represents 80% of all cases. In most cases when diagnosed, it is…”
Get full text

Pulmonary small cell carcinoma with heterotopic ossification—Unique case report and review of literature by Budimir, Bernard, Kukulj, Suzana, Serdarevic, Marina, Samarzija, Miroslav, Cucevic, Branka

Get full text

Therapeutic implication of molecular profiling in patients with non – small cell lung cancer by JAKOPOVIĆ, MARKO, SMOJVER – JEŽEK, SILVANA, CHALFE, NABIL, REDŽEPI, GZIM, JANKOVIĆ, MATEJA, ČUČEVIĆ, BRANKA, MIHELČIĆ, DINA, STANČIĆ – ROKOTOV, DINKO, SAMARŽIJA, MIROSLAV

“…Traditional, 'one size fits all' approach to chemotherapy has reached efficacy plateau. The development of molecular biomarkers is crucial for improving…”
Get full text

P30. Ki-67 expression in lung carcinoid tumors by Budimir, Bernard, Kukulj, Suzana, Brcic, Luka, Opasic, Luka, Cucevic, Branka, Serdarevic, Marina, Drpa, Gordana, Sovic, Slavica

Get full text

P11. Efficacy and safety of erlotinib in advanced squamous cell lung cancer by Jakopovic, Marko, Cucevic, Branka, Plestina, Sanja, Kukulj, Suzana, Roglic, Mihovil, Smojver-Jezek, Silvana, Korsic, Marta, Redzepi, Gzim, Samarzija, Miroslav

Get full text

P29. Oral topotecan in small cell lung cancer: treatment related side effects by Popovic, Filip, Samarzija, Miroslav, Kukulj, Suzana, Redzepi, Gzim, Roglic, Mihovil, Mursic, Davorka, Cucevic, Branka, Plestina, Sanja, Jakopovic, Marko

Get full text

Gemcitabine in the first and second-line chemotherapy of advanced non-small cell lung cancer by Cucević, Branka, Samarzija, Miroslav, Baricević, Denis, Jakopović, Marko, Redzepi, Gzim, Samija, Mirko

“…Aim of this study was to estimate efficacy of gemcitabine in first and the second-line chemotherapy for patients with advanced non-small cell lung cancer…”
Get more information

O-88 Gemcitabine and cisplatin (GC) +/-subsequent maintenance therapy with single-agent gemcitabine in advanced non-small cell lung cancer (NSCLC): Preliminary results of a randomized trial of the Central European Cooperative Oncology Group (CECOG) by Krzakowski, Maciel, Wenczl, Miklos, Brodowicz, Thomas, Tzekova, Valentina, Ramlau, Rodryg, Ghilezan, Nicolae, Cucevic, Branka, Gyurkovits, Kalman, Ernst, Ulsperger, Zielinski, Christoph, Zwitter, Matjaz

Get full text

CANCER PATIENTS FOLLOW-UP – CROATIAN SOCIETY FOR MEDICAL ONCOLOGY CLINICAL GUIDELINES Part V: melanoma, sarcomas, central nerve system tumors, lung cancer by Herceg, Davorin, Jakopović, Marko, Plavetić, Natalija Dedić, Samaržija, Miroslav, Čučević, Branka, Mijatović, Davor, Nikolić, Igor, Trivanović, Dragan, Šeparović, Robert, Vrbanec, Damir

“…Treatment of oncological patients must be based upon multidisciplinary approach, and takes place in specialized oncological centers. By the end of a specific…”
Get full text